RJA
TARS icon

Raymond James & Associates’s Tarsus Pharmaceuticals TARS Stock Holding History

Raymond James & Associates’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,111
Closed -$180K – 3883
2023
Q3 		$180K Buy
+10,111
New +$180K ﹤0.01% 3464